Biomarker Analysis of Patients With Previously Treated Metastatic Breast Cancer Treated With Neratinib + Capecitabine vs Lapatinib + Capecitabine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine vs Lapatinib + Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
Clin. Cancer Res 2021 Aug 11;[EPub Ahead of Print], C Saura, J Matito, M Oliveira, H Wildiers, AM Brufksy, SH Waters, SA Hurvitz, B Moy, SB Kim, WJ Gradishar, GS Queiroz, E Cronemberger, GJ Wallweber, J Bebchuk, K Keyvanjah, AS Lalani, R Bryce, A Vivancos, LD Eli, S DelalogeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.